Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 8 studies | 28% ± 11% | |
endothelial cell | 7 studies | 19% ± 4% | |
macrophage | 5 studies | 33% ± 4% | |
astrocyte | 5 studies | 32% ± 12% | |
cardiac muscle cell | 4 studies | 18% ± 3% | |
fibroblast | 4 studies | 18% ± 2% | |
microglial cell | 4 studies | 31% ± 11% | |
myeloid cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of MAP3K14 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 1821.52 | 359 / 359 | 100% | 11.42 | 285 / 286 |
esophagus | 100% | 2193.01 | 1445 / 1445 | 99% | 13.30 | 182 / 183 |
intestine | 100% | 3270.34 | 966 / 966 | 99% | 9.92 | 524 / 527 |
skin | 100% | 1581.61 | 1808 / 1809 | 99% | 12.15 | 469 / 472 |
lung | 100% | 2164.82 | 577 / 578 | 99% | 10.53 | 1141 / 1155 |
uterus | 100% | 1766.10 | 170 / 170 | 98% | 12.36 | 452 / 459 |
prostate | 100% | 2151.14 | 245 / 245 | 98% | 7.82 | 494 / 502 |
pancreas | 99% | 1026.36 | 326 / 328 | 99% | 10.99 | 176 / 178 |
thymus | 100% | 1685.25 | 652 / 653 | 98% | 10.96 | 595 / 605 |
breast | 100% | 1725.28 | 459 / 459 | 98% | 9.94 | 1096 / 1118 |
bladder | 100% | 1817.48 | 21 / 21 | 97% | 8.58 | 487 / 504 |
ovary | 100% | 1424.09 | 180 / 180 | 95% | 5.88 | 410 / 430 |
liver | 100% | 977.77 | 226 / 226 | 95% | 10.74 | 386 / 406 |
kidney | 100% | 1591.10 | 89 / 89 | 94% | 18.02 | 849 / 901 |
adrenal gland | 100% | 990.59 | 258 / 258 | 94% | 6.88 | 216 / 230 |
brain | 90% | 864.36 | 2391 / 2642 | 100% | 11.11 | 703 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.18 | 29 / 29 |
muscle | 100% | 3658.64 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2935.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.97 | 1 / 1 |
adipose | 100% | 1534.03 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 875.20 | 1319 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1604.83 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 20.73 | 44 / 45 |
peripheral blood | 96% | 1870.88 | 894 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 6.82 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0006955 | Biological process | immune response |
GO_0051607 | Biological process | defense response to virus |
GO_0038061 | Biological process | non-canonical NF-kappaB signal transduction |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0000165 | Biological process | MAPK cascade |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0001650 | Cellular component | fibrillar center |
GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | MAP3K14 |
Protein name | Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (HsNIK) (Serine/threonine-protein kinase NIK) Mitogen-activated protein kinase kinase kinase 14 |
Synonyms | NIK |
Description | FUNCTION: Lymphotoxin beta-activated kinase which seems to be exclusively involved in the activation of NF-kappa-B and its transcriptional activity. Phosphorylates CHUK/IKKA, thereby promoting proteolytic processing of NFKB2/P100, which leads to NF-kappa-B activation via the non-canonical pathway . Has an essential role in the non-canonical NF-kappa-B signaling that regulates genes encoding molecules involved in B-cell survival, lymphoid organogenesis, and immune response . Could act in a receptor-selective manner. . |
Accessions | ENST00000376926.8 A0A087WXF1 ENST00000680632.1 ENST00000617331.3 ENST00000344686.8 ENST00000617331 Q99558 A0A7P0Z419 |